Biostax Corp.
BTAX
$0.01
$0.00111.11%
06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 15.91% | 22.55% | 5.22% | -44.62% | -14.79% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | -31.43% | -33.97% | 9.07% | -16.30% | 49.78% |
Operating Income | 31.43% | 33.97% | -9.07% | 16.30% | -49.78% |
Income Before Tax | 15.11% | 18.99% | -277.73% | 84.41% | -128.12% |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | 15.11% | 18.99% | -277.73% | 84.41% | -128.12% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 15.11% | 18.99% | -277.73% | 84.41% | -128.12% |
EBIT | 31.43% | 33.97% | -9.07% | 16.30% | -49.78% |
EBITDA | 32.45% | 35.17% | -- | -- | -- |
EPS Basic | 16.39% | 20.00% | -270.59% | 88.67% | -100.24% |
Normalized Basic EPS | 15.79% | 19.35% | -33.33% | 35.56% | -100.15% |
EPS Diluted | 0.00% | 20.00% | -223.08% | 88.67% | -104.35% |
Normalized Diluted EPS | 15.79% | 19.35% | -33.33% | 35.56% | -101.65% |
Average Basic Shares Outstanding | 0.50% | 0.56% | 0.51% | 38.53% | 11,852.51% |
Average Diluted Shares Outstanding | 0.50% | 3.05% | 0.51% | 38.53% | 967.14% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |